#weight-regain

#weight-regain

Last month, the World Health Organization updated its guidelines for GLP-1 drugs like Ozempic and Wegovy. Among the guidelines were several conditional recommendations, as well as a perspective that took the long view, temporally speaking. "Our new guidance recognizes that obesity is a chronic disease that can be treated with comprehensive and lifelong care," Dr. Tedros Adhanom Ghebreyesus, the organization's Director-General, said in a statement.That "lifelong" isn't said lightly.

"These drugs are very effective at helping you lose weight, but when you stop them, weight regain is much faster than after stopping diets," said Susan Jebb.